Correlation Between Scopus Biopharma and Heron Therapeuti

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Scopus Biopharma and Heron Therapeuti at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scopus Biopharma and Heron Therapeuti into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scopus Biopharma and Heron Therapeuti, you can compare the effects of market volatilities on Scopus Biopharma and Heron Therapeuti and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scopus Biopharma with a short position of Heron Therapeuti. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scopus Biopharma and Heron Therapeuti.

Diversification Opportunities for Scopus Biopharma and Heron Therapeuti

-0.25
  Correlation Coefficient

Very good diversification

The 3 months correlation between Scopus and Heron is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Scopus Biopharma and Heron Therapeuti in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Heron Therapeuti and Scopus Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scopus Biopharma are associated (or correlated) with Heron Therapeuti. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Heron Therapeuti has no effect on the direction of Scopus Biopharma i.e., Scopus Biopharma and Heron Therapeuti go up and down completely randomly.

Pair Corralation between Scopus Biopharma and Heron Therapeuti

If you would invest  10.00  in Scopus Biopharma on October 12, 2024 and sell it today you would earn a total of  0.00  from holding Scopus Biopharma or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy0.53%
ValuesDaily Returns

Scopus Biopharma  vs.  Heron Therapeuti

 Performance 
       Timeline  
Scopus Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Scopus Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Scopus Biopharma is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.
Heron Therapeuti 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Heron Therapeuti has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Heron Therapeuti is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Scopus Biopharma and Heron Therapeuti Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Scopus Biopharma and Heron Therapeuti

The main advantage of trading using opposite Scopus Biopharma and Heron Therapeuti positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scopus Biopharma position performs unexpectedly, Heron Therapeuti can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heron Therapeuti will offset losses from the drop in Heron Therapeuti's long position.
The idea behind Scopus Biopharma and Heron Therapeuti pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Commodity Directory
Find actively traded commodities issued by global exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules